GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a prominent focus in therapeutic investigation, largely due to its notable impact on controlling conditions such as second type diabetes and excess body fat. New studies have demonstrated that beyond glucose regulation, GLP-1 medications offer benefits for cardiovascular wel